Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand · Injection

Epogen 20000 units/mL injection price what pharmacies pay, and what you should

There is no weekly pharmacy acquisition cost for epogen 20000 units/ml injection this week. The makers, package codes, recalls and label are below.

What did you pay for epogen 20000 units/ml injection? Share it.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Supply status: shortages & recalls

No shortage reportedChecked Nov 17, 2026
No ongoing recalls1 recall on record

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

Every manufacturer and package code

1 company sell epogen 20000 units/ml injection under 1 package code (NDC).

MakerPack sizesPackage codesPer unit
Amgen, Inc1055513-478-10 -
All 1 package codes

A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.

Other epogen strengths and forms

Strength and formPer unitPharmacies pay4 weeks52 weeks
2000 units/mL, 1 mL injection Brand$32.27$322.67 / 10 mLNo change-0.3%
4000 units/mL, 1 mL injection Brand$64.36$643.64 / 10 mLNo changeNo change
10000 units/mL, 1 mL injection Brand$161.82$1,618.21 / 10 mLNo change+0.1%

Official label & what changed

Last changedJuly 1, 2026
Version137 of 19
EffectiveJun 23, 2026
Read the label

These highlights do not include all the information needed to use EPOGEN safely and effectively. See full prescribing information for EPOGEN. EPOGEN® (epoetin alfa) injection, for intravenous or subcutaneous useInitial U.S. Approval: 1989

This drug has a boxed warning

WARNING: ESAs INCREASE THE RISK OF DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE

Chronic Kidney Disease:

In controlled trials, patients with chronic kidney disease (CKD) experienced greater risks for death, serious adverse cardiovascular reactions, and stroke when administered erythropoiesis-stimulating agents (ESAs) to target a hemoglobin level of greater than 11 g/dL [see Warnings and Precautions (5.1)].

No trial has identified a hemoglobin target level, ESA dose, or dosing strategy that does not increase these risks [see Dosage and Administration (2.2)].

Use the lowest Epogen dose sufficient to reduce the need for red blood cell (RBC) transfusions [see Warnings and Precautions (5.1)].

Cancer:

ESAs shortened overall survival and/or increased the risk of tumor progression or recurrence in clinical studies of patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers [see Warnings and Precautions (5.2)].

To decrease these risks, as well as the risk of serious cardiovascular and thromboembolic reactions, use the lowest dose needed to avoid RBC transfusions [see Dosage and Administration (2.4)].

Use ESAs only for anemia from myelosuppressive chemotherapy [see Indications and Usage (1.3)].

ESAs are not indicated for patients receiving myelosuppressive chemotherapy when the anticipated outcome is cure [see Indications and Usage (1.5)].

Discontinue following the completion of a chemotherapy course [see Dosage and Administration (2.4)].

Perisurgery:

Due to increased risk of Deep Venous Thrombosis (DVT), DVT prophylaxis is recommended [see Dosage and Administration (2.5), Warnings and Precautions (5.1)].

WARNING: ESAs INCREASE THE RISK OF DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE

See full prescribing information for complete boxed warning.

Chronic Kidney Disease:

In controlled trials, patients experienced greater risks for death, serious adverse cardiovascular reactions, and stroke when administered erythropoiesis-stimulating agents (ESAs) to target a hemoglobin level of greater than 11 g/dL (5.1).

No trial has identified a hemoglobin target level, ESA dose, or dosing strategy that does not increase these risks (2.2).

Use the lowest Epogen dose sufficient to reduce the need for red blood cell (RBC) transfusions (5.1).

Cancer:

ESAs shortened overall survival and/or increased the risk of tumor progression or recurrence in clinical studies of patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers (5.2).

Use the lowest dose to avoid RBC transfusions (2.4).

Use ESAs only for anemia from myelosuppressive chemotherapy (1.3).

ESAs are not indicated for patients receiving myelosuppressive chemotherapy when the anticipated outcome is cure (1.5).

Discontinue following the completion of a chemotherapy course (2.4).

Perisurgery:

Due to increased risk of deep venous thrombosis (DVT), DVT prophylaxis is recommended (5.1).

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Questions about epogen 20000 units/ml injection

Who makes epogen 20000 units/ml injection?

1 company: Amgen, Inc. See every package code.

Is epogen in shortage?

No shortage is reported right now. We check every day.

Has epogen been recalled?

1 recall on record. Recalls name specific lots - check yours.

What does "pharmacies pay" mean?

It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.

Talk about epogen 20000 units/ml injection

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.